Serum markers of collagen type I metabolism in spontaneously hypertensive rats: Relation to myocardial fibrosis

Circulation

Volumn 93, Issue 5, 1996, Pages 1026-1032

  Díez, Javier ^a,c   Panizo, Angel ^b   Gil, María J ^b   Monreal, Ignacio ^b   Hernández, Marta ^a   Mindán, Javier Pardo ^b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

collagen; fibrosis; hypertension; peptides

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROCOLLAGEN; QUINAPRIL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; COLLAGEN METABOLISM; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029962782     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.5.1026     Document Type: Article

References (38)

1. Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol. 1979;6:H461-H468.
2. Sen S, Bumpus FM. Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Am J Cardiol. 1979;44:954-958.
3. Huysman JAN, Vliegen HW, Vanderlaarse A, Eulderink F. Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophied human hearts. Pathol Res Pract. 1989; 184:577-581.
4. Pardo-Mindán FJ, Panizo A. Alterations in the extracellular matrix of the myocardium in essential hypertension. Eur Heart J. 1993; 14(suppl J):12-14.
5. Mukherjee D, Sen S. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ Res. 1990;67:1474-1480.
6. Weber KT, Sun Y, Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension. 1994;23(pt 2):869-877.
7. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular dysfunction by captopril in the spontaneously hyper tensive rat. Proc Natl Acad Sci USA. 1992;79:3310-3316.
8. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991;83:1771-1779.
9. Panizo A, Pardo J, Hernández M, Galindo MF, Cenarruzabeitia E, Díez J. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens. 1995;8:815-822.
10. Schwartzkopff B, Motz W, Strauer BE. Repair of human myocardial structure by chronic treatment with ACE-inhibitors in hypertensive heart disease. Circulation. 1994;90(suppl I):I-343. Abstract.
11. Miyahara M, Njieha FK, Prockop DJ. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases. J Biol Chem. 1982;257:8442-8448.
12. Carey DE, Goldberg D, Ratzan SK, Rubin KR, Rowe DW. RIA for type 1 procollagen in growth hormone-deficient children before and during treatment with growth hormone. Pediatr Res. 1985;19:8-11.
13. Schuppan D. Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis. J Hepatol. 1991;13(suppl 3):S17-S25.
14. Parfitt AM, Simon LS, Villanueva AR, Krane SM. Procollagen type I carboxy-terminal extension peptide in serum as marker of collagen biosynthesis in bone: correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res. 1987;2:427-436.
15. Alexander CM, Werb Z. Extracellular matrix degradation. In: Hay ED, ed. Cell Biology of Extracellular Matrix. 2nd ed. New York, NY: Plenum Press; 1991:255-275.
16. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 1993;39:635-640.
17. Eriksen EF, Charles P, Meisen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type 1 collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res. 1993;8:127-132.
18. Autio P, Risteli J, Kiistala U, Risteli L, Karvonen J, Oikarinen A. Serum markers of collagen synthesis and degradation in skin diseases: altered levels in diseases with systemic manifestations and during systemic glucocorticoid treatment. Arch Dermatol Res. 1993; 285:322-327.
19. Díez J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alterations. Circulation. 1995;91:1450-1456.
20. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem. 1990;36:1328-1332.
21. Smedrod B, Melkko J, Risteli L, Risteli J. Circulating C-terminal propeptide of type I procollagen is cleared mainly via a mannose receptor in the liver endothelial cells. Biochem J. 1990;271:345-350.
22. Yamori Y. Physiopathology of the various strains of spontaneously hypertensive rats. In: Genest J, Kuchel O, Harriet P, Cantin M, eds. Hypertension. New York, NY: McGraw-Hill; 1983:556-581.
23. McAnulty RJ, Laurent GJ. Collagen synthesis and degradation in vivo: evidence for rapid rates of collagen turnover with extensive degradation of newly synthesized collagen in tissues of the adult rat. Collagen Relat Res. 1987;7:93-104.
24. Medugorac I, Jacob R. Characterization of left ventricular collagen in the rat. Cardiovasc Res. 1983;17:15-21.
25. Baker HJ, Lindsey JR, Weisbroth SH. Appendix 1: selective normative data. In: Baker HJ, Lindsey JR, Weisbroth SH, eds. The Laboratory Rat: Research Applications. New York, NY: Academic Press; 1980:257-258.
26. Okamoto K. Spontaneous hypertension in rats. Int Rev Exp Pathol. 1969;7:227-270.
27. Charles P, Mosekilde L, Risteli L, Risteli J, Eriksen EF. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. J Bone Miner Res. 1994;24:81-94.
28. Iwatsuki K, Cardinale GJ, Spector S, Udenfriend S. Hypertension: increase of collagen biosynthesis in arteries but not in veins. Science. 1977;198:403-405.
29. Bashey RI, Cox R, McCann J, Jiménez SA. Changes in collagen biosynthesis, types, and mechanics of aorta in hypertensive rats. J Lab Clin Med. 1989;113:604-611.
30. Kaplan HR, Taylor DG, Olson SC, Andrews LK. Quinapril: a preclinical review of the pharmacology, pharmacokinetics and toxicology. Angiology. 1989;40:335-350.
31. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809-820.
32. Laurent GL. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol. 1987;252:C1-C9.
33. Schimke RT, Doyle D. Control of enzyme levels in animal tissues. Annu Rev Biochem. 1970;39:929-976.
34. Robins SP. Turnover and cross-linking of collagen. In: Weiss JB, Jayson MIV, eds. Collagen in Health and Disease. Edinburgh, Scotland: Churchill-Livingstone; 1982:160-178.
35. Robins SP, Stewart P, Astbury C, Brid HA. Measurement of the cross-linking compound, pyridoline, in urine as an index of collagen degradation in joint disease. Ann Rheum Dis. 1986;45:969-973.
36. Doering CW, Jalil JE, Janicki JS, Pick R, Aghili S, Abrahams C, Weber KT. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res. 1988;22:686-695.
37. Laurent GJ, Bates PC, Sparrow MP, Millward DJ. Muscle protein turnover in the adult fowl, III: collagen content and turnover in cardiac and skeletal muscles in the adult fowl (Gallus domesticus) and the changes during stretch-induced growth. Biochem J. 1978; 176:419-427.
38. Brilla CG, Campbell SE, Matsubara L, Weber KT. Advanced hypertensive heart disease in SHR: lisinopril-mediated regression of myocardial fibrosis. Circulation. 1992;86(suppl I):I-329. Abstract.